Pericardiocentesis Versus Pericardiotomy for Malignant Pericardial Effusion: a Retrospective Comparison

Total Page:16

File Type:pdf, Size:1020Kb

Pericardiocentesis Versus Pericardiotomy for Malignant Pericardial Effusion: a Retrospective Comparison MALIGNANT PERICARDIAL EFFUSION, Labbé et al. ORIGINAL ARTICLE Pericardiocentesis versus pericardiotomy for malignant pericardial effusion: a retrospective comparison C. Labbé MD,* L. Tremblay MD,* and Y. Lacasse MD MSc* ABSTRACT Background Treatment of malignant pericardial effusion remains controversial, because no randomized controlled trials have been conducted to determine the best approach, and results of retrospective studies have been inconsistent. The objective of the present study was to compare pericardiocentesis and pericardiotomy with respect to efficacy for preventing recurrence, and to determine, for those two procedures, diagnostic yields, complication rates, and effects on survival. We also aimed to identify clinical and procedural factors that could predict effusion recurrence. Methods We retrospectively assessed 61 patients who underwent a procedure for treatment of a malignant pericardial effusion at the Institut universitaire de cardiologie et de pneumologie de Québec between February 2004 and September 2013. Results Pericardiocentesis was performed in 42 patients, and pericardiotomy, in 19 patients. The effusion recurrence rate was significantly higher in patients treated with pericardiocentesis than with pericardiotomy (31.0% vs. 5.3%, p = 0.046). The diagnostic yield of the procedures was not significantly different (92.9% vs. 86.7%, p = 0.6). The overall rate of complications was similar in the two groups, as was the median overall survival (2.4 months vs. 2.6 months, p = 0.5). In univariate analyses, the procedure type was the only predictor of recurrence that approached statistical significance. Age, sex, type of cancer, presence of effusion at the time of cancer diagnosis, prior chest irradiation, tamponade upon presentation, and total volume of fluid removed did not influence the recurrence rate. Conclusions Compared with pericardiocentesis, pericardiotomy had higher success rate in preventing recurrence of malignant pericardial effusion, with similar diagnostic yields, complication rates, and overall survival. Key Words Malignant pericardial effusion, pericardiocentesis, pericardiotomy, recurrence, complications, diagnostic yield, survival Curr Oncol. 2015 Dec;22(6):412-416 www.current-oncology.com INTRODUCTION toxicity, and opportunistic infections related to immuno- suppressive therapies3. Despite treatment, median overall Malignant pericardial effusion is a common problem in survival in patients with malignant pericardial effusion is oncology, and the primary tumour that most frequently reported to be in the range of 2–4 months and is influenced involves the pericardium is lung cancer1. Patients are often mainly by the nature of the underlying malignancy, lung asymptomatic, but they can also present with cardiorespi- cancer being a poor prognostic factor4. ratory symptoms (for example, dyspnea, cough, chest pain), For patients with advanced cancer involving the clinical signs (tachycardia, for instance), echocardio- pericardium, the goals of treatment should be to use a graphic features of right heart compromise, and possibly minimally invasive procedure with a good safety profile life-threatening cardiac tamponade requiring emergency to achieve symptom relief, improvement in quality of life, drainage2. Malignancies can involve the pericardium by and prevention of recurrence. Several approaches can be four mechanisms: direct extension or metastatic spread via used to treat malignant pericardial effusion, but no ran- lymphatics or blood, chemotherapeutic toxicity, radiation domized controlled trials have been conducted to compare Correspondence to: Catherine Labbé, Centre de Pneumologie, Institut universitaire de cardiologie et de pneumologie de Québec, 2725 chemin Ste-Foy, Québec, Québec G1V 4G5. E-mail: [email protected] n DOI: http://dx.doi.org/10.3747/co.22.2698 412 Current Oncology, Vol. 22, No. 6, December 2015 © 2015 Multimed Inc. MALIGNANT PERICARDIAL EFFUSION, Labbé et al. their risk–benefit ratio; no “gold standard” has been estab- Statistical Analysis lished; and practices differ widely. Many authors believe Descriptive statistics (proportions, means, standard devi- that treatment must be individualized according to the ations, and ranges) are used to describe the study popu- patient’s condition and tumour type, and to the success lation. Clinical characteristics of the patients treated with rates and risks of the various options, local availability, pericardiocentesis and those treated with pericardiotomy and expertise5. were compared using chi-square tests for dichotomous One consensus is that cardiac tamponade is a clear variables and unpaired t-tests for continuous variables. indication for urgent pericardiocentesis. For effusions We used univariate analyses to test the influence of each without tamponade, guidelines from the European Soci- baseline clinical characteristic and treatment (that is, ety of Cardiology state that pericardiocentesis can relieve pericardiocentesis or pericardiotomy) on risk of recur- symptoms and establish diagnosis, and that systemic rence. Fine–Gray Cox models were constructed to account antineoplastic treatment and intrapericardial instillation for death as a competing risk event for recurrence14. For of a cytostatic or sclerosing agent can prevent recurrence6. both groups, Kaplan–Meier estimates were used to con- Subxiphoid pericardiotomy is indicated when pericar- struct survival curves, and the log-rank test was used for diocentesis cannot be performed. Extended catheter between-group comparisons. In all analyses, statistical drainage after pericardiocentesis, percutaneous balloon significance (p value) was set at the 0.05 level. pericardiotomy, and various other surgical approaches are also possible options to prevent recurrence. They have RESULTS been compared, with inconsistent results, in many retro- spective studies7–11. Recently, a retrospective analysis in Patients 88 patients showed that, compared with surgical pericar- Of the 61 patients included in the study, 42 (69%) were diotomy, pericardiocentesis with extended drainage had treated with pericardiocentesis, and 19 (31%) underwent the same diagnostic yield, the same recurrence rate, and pericardiotomy (7 by the subxiphoid approach, 5 by per- fewer complications12; and a systematic review including cutaneous balloon procedure, 4 by left mini-thoracotomy, 1399 patients concluded that surgical drainage is superior 1 by left video-assisted thoracic surgery, 1 by laparoscopy, to nonsurgical approaches in terms of symptom relief, and 1 by sternotomy). Most of the patients (n = 52, 85%) had effusion recurrence, and morbidity13. lung cancer (46 adenocarcinomas, 2 squamous cell cancers, The objective of our study was to compare pericardio- 2 small-cell lung cancers, 2 non-small-cell lung cancers centesis with pericardiotomy in respect of their efficacy for not otherwise specified). Other diagnoses included breast preventing recurrence in patients with malignant pericar- cancer in 5 patients, and single cases of mesothelioma, dial effusion, and to determine the diagnostic yields, com- uterine cancer, bladder cancer, and adenocarcinoma of plication rates, and effect on survival of the two procedures. unknown origin. We also aimed to identify clinical and procedural factors Table i shows the baseline characteristics of the pa- that could predict effusion recurrence. tients. The only significant difference was that the pericar- diocentesis group contained a higher proportion of patients METHODS with pulmonary neoplasms. Almost all the patients treated with pericardiocentesis underwent prolonged drainage, Patients with the pericardial catheter left in place for at least 24 We retrospectively reviewed the medical records of all hours and up to 7 days, until drainage stopped. Only 1 patients who underwent a procedure for malignant peri- patient underwent local sclerotherapy with bleomycin. cardial effusion at the Institut universitaire de cardiologie et de pneumologie de Québec between February 2004 Clinical Outcomes and September 2013. The study was carried out with the The overall rate of pericardial effusion recurrence was approval of the institute’s ethics committee review board 23%, and the rate was significantly different in the two (CÉR 21060). The study population was divided into two groups (31.0% pericardiocentesis vs. 5.3% pericardiotomy, groups, and patients treated with pericardiocentesis under p = 0.046; Table ii). In the univariate analyses, procedure local anesthesia and ultrasound guidance were compared type was the only predictor of recurrence that approached with patients who underwent surgical or percutaneous the level of statistical significance (hazard ratio: 0.154; balloon pericardiotomy. Because this study was retrospec- p = 0.08). Age, sex, type of cancer, presence of effusion tive, the choice of the therapeutic intervention was at the at the time of cancer diagnosis, prior chest irradiation, treating physician’s discretion. tamponade on presentation, and total volume of fluid removed had no influence on the recurrence rate. The Data Extraction mean interval between the procedure and effusion re- The medical records of the patients were searched for currence was 90 days. Of the 13 patients with recurrence patient age and sex, type of cancer, presence of pericar- after pericardiocentesis, 9 were subsequently treated with dial effusion at the time of cancer diagnosis, prior chest pericardiotomy, 3 underwent repeat pericardiocentesis, irradiation, tamponade upon
Recommended publications
  • Pericardial Injury with Cardiac Tamponade from Multiple Stab Injuries of the Trunk: Incidental Release of Cardiac Tamponade
    eISSN: 2508-8033 Treatment Progression in Trauma pISSN: 2508-5298 Pericardial Injury With Cardiac Tamponade From Multiple Stab Injuries of the Trunk: Incidental Release of Cardiac Tamponade Pil Young Jung1, Kwan Wook Kim2 1Department of Surgery, Yonsei university Wonju college of medicine, Wonju Severance Christian Hospital 2Trauma center, Department of Thoracic and Cardiovascular Surgery, CHA University, CHA Bundang Medical Center Traumatic hemopericardium with cardiac tamponade is a rare but life-threatening condition. We report the successful treatment of hemopericardium with cardiac tamponade caused by multiple stab injuries of the trunk. (Trauma Image Proced 2019(1):22-24) Key Words: Hemopericardium, Cardiac tamponade CASE tion of the left internal mammary vessels, which was the cause of hemopericardium (Fig. 3.). The epicardium of From a regional local hospital, a 34-year-old man the right ventricle, the greater omentum, and the spleen who had schizophrenia was transferred to our institution were injured; the diaphragmatic injury may have served with multiple stab injuries of the trunk, sustained in a as a pericardial window of injury into the abdomen suicide attempt (Fig. 1.). At admission, the patient’s vital cavity. We performed ligation of the left internal signs were unstable; cardiac arrest occurred, and return mammary vessels, splenectomy, omentectomy, and of spontaneous circulation was achieved after one cycle primary repair of the diaphragm. The patient recovered of cardiopulmonary resuscitation. The extended focused and was discharged without any complication 24 days assessment sonography in trauma revealed positive signs after admission (Fig. 4.). in the pericardium and splenorenal space. Computed tomographic scans taken at the previous hospital showed DISCUSSION hemopericardium and hemoperitoneum (Fig.
    [Show full text]
  • Appendix A: Surgical Procedure Terms and Definitions
    Appendix A: Surgical Procedure Terms and Definitions Anomalous Systemic Venous Connection Anomalous Systemic Venous Connection Repair Repair includes a range of surgical approaches, including, among others: ligation of anomalous vessels, reimplantation of anomalous vessels (with or without use of a conduit), or redirection of anomalous systemic venous flow through directly to the pulmonary circulation (bidirectional Glenn to redirect LSVC or RSVC to left or right pulmonary artery, respectively). Aortic Aneurysm Aortic aneurysm repair Aortic aneurysm repair by any technique. Aortic Dissection Aortic Dissection repair Aortic dissection repair by any technique. Aortic Root Replacement Aortic Root Replacement, Bioprosthetic Replacement of the aortic root (that portion of the aorta attached to the heart; it gives rise to the coronary arteries) with a bioprosthesis (e.g., porcine) in a conduit, often composite. Aortic Root Replacement, Mechanical Replacement of the aortic root (that portion of the aorta attached to the heart; it gives rise to the coronary arteries) with a mechanical prosthesis in a composite conduit. Aortic Root Replacement, Homograft Replacement of the aortic root (that portion of the aorta attached to the heart; it gives rise to the coronary arteries) with a homograft Aortic Root Replacement, Valve sparing Replacement of the aortic root (that portion of the aorta attached to the heart; it gives rise to the coronary arteries) without replacing the aortic valve (using a tube graft). Aortic Valve Disease Ross Procedure Replacement of the aortic valve with a pulmonary autograft and replacement of the pulmonary valve with a homograft conduit. Konno Procedure (with and without aortic valve replacement) Relief of left ventricular outflow tract obstruction associated with aortic annular hypoplasia, aortic valvar stenosis and/or aortic valvar insufficiency via Konno aortoventriculoplasty.
    [Show full text]
  • ICD-9-CM Procedures (FY10)
    2 PREFACE This sixth edition of the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) is being published by the United States Government in recognition of its responsibility to promulgate this classification throughout the United States for morbidity coding. The International Classification of Diseases, 9th Revision, published by the World Health Organization (WHO) is the foundation of the ICD-9-CM and continues to be the classification employed in cause-of-death coding in the United States. The ICD-9-CM is completely comparable with the ICD-9. The WHO Collaborating Center for Classification of Diseases in North America serves as liaison between the international obligations for comparable classifications and the national health data needs of the United States. The ICD-9-CM is recommended for use in all clinical settings but is required for reporting diagnoses and diseases to all U.S. Public Health Service and the Centers for Medicare & Medicaid Services (formerly the Health Care Financing Administration) programs. Guidance in the use of this classification can be found in the section "Guidance in the Use of ICD-9-CM." ICD-9-CM extensions, interpretations, modifications, addenda, or errata other than those approved by the U.S. Public Health Service and the Centers for Medicare & Medicaid Services are not to be considered official and should not be utilized. Continuous maintenance of the ICD-9- CM is the responsibility of the Federal Government. However, because the ICD-9-CM represents the best in contemporary thinking of clinicians, nosologists, epidemiologists, and statisticians from both public and private sectors, no future modifications will be considered without extensive advice from the appropriate representatives of all major users.
    [Show full text]
  • ICD-9-CM Coordination and Maintenance Committee Meeting September 28-29, 2006 Diagnosis Agenda
    ICD-9-CM Coordination and Maintenance Committee Meeting September 28-29, 2006 Diagnosis Agenda Welcome and announcements Donna Pickett, MPH, RHIA Co-Chair, ICD-9-CM Coordination and Maintenance Committee ICD-9-CM TIMELINE .................................................................................................... 2 Hearing loss, speech, language, and swallowing disorders ........................................... 8 Kyle C. Dennis, Ph.D., CCC-A, FAAA and Dee Adams Nikjeh,Ph.D., CCC-SLP American Speech-Language-Hearing Association Urinary risks factors for bladder cancer ...................................................................... 13 Louis S. Liou, M.D., Ph.D., Abbott Chronic Total Occlusion of Artery of Extremities....................................................... 15 Matt Selmon, M.D., Cordis Osteonecrosis of jaw ....................................................................................................... 17 Vincent DiFabio,M.D., American Association of Oral and Maxillofacial Surgeons Intraoperative Floppy Iris Syndrome ........................................................................... 18 Priscilla Arnold, M.D., American Society of Cataract and Refractive Surgery Septic embolism............................................................................................................... 19 Parvovirus B19 ................................................................................................................ 21 Avian Influenza (Bird Flu)............................................................................................
    [Show full text]
  • Instructions and Data Element Definitions Form DOH-2254A
    NEW YORK STATE DEPARTMENT OF HEALTH DIVISION OF QUALITY AND PATIENT SAFETY CARDIAC SERVICES PROGRAM 2014 Discharges Cardiac Surgery Report, Adult (Age 18 and Over) Instructions and Data Element Definitions Form DOH-2254a CARDIAC SERVICES PROGRAM CONTACTS: One University Place, Suite 218 Rensselaer, NY 12144-3455 Phone: (518) 402-1016 Fax: (518) 402-6992 Kimberly S. Cozzens, MA, Cardiac Initiatives Research Manager, [email protected] Rosemary Lombardo, MS, CSRS Coordinator, [email protected] Table of Contents Topic Page Revision Highlights and Coding Clarifications…………………..…………… 6 When to Complete an Adult CSRS Form ……………………………………. 6 Guidance on Selecting Appropriate Procedure Codes ………………….... 8 CSRS Data Reporting Policies ……………………………………….………. 10 ITEM-BY-ITEM INSTRUCTIONS PFI Number ………………………………………………………………... 12 Sequence Number ………………………………………………………... 12 I. Patient Information Patient Name ……………………………………………………………… 12 Medical Record Number …………………………………………………. 12 Social Security Number ………………………………………………….. 12 Date of Birth ………………………….………………………….………… 12 Sex ………………………….………………………….…………………… 13 Ethnicity ………………………….………………………….……………... 13 Race ………………………….…………………………………………….. 13 Residence Code ………………………….……………………………….. 14 Hospital Admission Date ………………………….……………………… 14 Primary Payer ………………………….………………………………….. 14 Medicaid ………………………….………………………….…………….. 15 PFI of Transferring Hospital ………………………….………………….. 15 II. Procedural Information Hospital That Performed Diagnostic Cath ………………………….…… 16 Date of Surgery ………………………….…………………………………
    [Show full text]
  • NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Pediatric Cardiac Surgery Measures
    NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Pediatric Cardiac Surgery Measures Measure Number: PCS‐001‐09 Measure Title: Participation in a national database for pediatric and congenital heart surgery Description: Participation in at least one multi‐center, standardized data collection and feedback program that provides benchmarking of the physician’s data relative to national and regional programs and uses process and outcome measures. Participation is defined as submission of all congenital and pediatric operations performed to the database. Numerator Statement: Whether or not there is participation in at least one multi‐center data collection and feedback program. Denominator Statement: N/A Level of Analysis: Group of clinicians, Facility, Integrated delivery system, health plan, community/population Data Source: Electronic Health/Medical Record, Electronic Clinical Database (The Society of Thoracic Surgeons Congenital Heart Surgery Database), Electronic Clinical Registry (The Society of Thoracic Surgeons Congenital Heart Surgery Database), Electronic Claims, Paper Medical Record Measure Developer: Society of Thoracic Surgeons Type of Endorsement: Recommended for Time‐Limited Endorsement (Steering Committee Vote, Yes‐9, No‐0, Abstain‐0) Attachments: “STS Attachment: STS Procedure Code Definitions” Meas# / Title/ Steering Committee Evaluation and Recommendation (Owner) PCS-001-09 Recommendation: Time-Limited Endorsement Yes-9; No-0; Abstain-0 Participatio n in a Final Measure Evaluation Ratings: I: Y-9; N-0 S: H-4; M-4; L-1 U: H-9; M-0; L-0 national F: H-7; M-2; L-0 database for Discussion: pediatric I: The Steering Committee agreed that this measure is important to measure and report. and By reporting through a database, it is possible to identify potential quality issues and congenital provide benchmarks.
    [Show full text]
  • Emergency Open Cardiac Massage Via Subxyphoid Approach in Ruptured Type a Aortic Dissection
    SIGNA VITAE 2010; 5(2): 32 -34 CASE REPORT CHAO-WEN CHEN ( ) Department of Trauma Emergency Open Cardiac Kaohsiung Medical University Hospital 100 Tzyou 1st Road Kaohsiung 807, Taiwan Phone: +88673125895 ext 7553 Massage via Subxyphoid Fax: +88673208255 Approach in Ruptured Type E-mail: [email protected] HSING-LIN LIN • WEI-CHE LEE • SHING-GHI LIN • LIANG-CHI KUO • A Aortic Dissection YUAN-CHIA CHENG Department of Trauma Kaohsiung Medical University Hospital HSING-LIN LIN • WEI-CHE LEE • SHING-GHI LIN • LIANG-CHI KUO • Kaohsiung Medical University YUAN-CHIA CHENG • CHAO-WEN CHEN Kaohsiung, Taiwan HSING-LIN LIN • WEI-CHE LEE KUO • YUAN-CHIA CHENG Department of emergency Kaohsiung Medical University Hospital Kaohsiung Medical University Kaohsiung, Taiwan HSING-LIN LIN Division of General Surgery Department of Surgery Kaohsiung Medical University Hospital Kaohsiung Medical University Kaohsiung, Taiwan HSING-LIN LIN MD Graduate Institute of Healthcare Administration Kaohsiung Medical University Kaohsiung, Taiwan ABSTRACT Patient sustained cardiac tamponade caused by rupture of type A aortic dissection may result in sudden death. Pericardio- centesis is a lifesaving procedure; nevertheless, blood may occlude the catheter and fail to relieve the pressure. However, open-chest cardiac massage in resuscitation has been studied in animal models by some medical centers and laboratories with inspiring results. We report a 58-year-old woman who was transferred from a local hospital with the diagnosis of cardiac tamponade caused by ruptured type A aortic dissection. Pulseless electrical activity followed by cardiac arrest occurred thereafter. Successful resuscitation in the emergency department was achieved using open cardiac massage through the sub-xyphoid region by opening a pericardial window.
    [Show full text]
  • The 2012 Coding Manual Collection
    The 2012 Coding Manual Collection SaMple pageS ICD-9-CM Manual, Volumes 1, 2 & 3 (Hospital Edition) ICD-9-CM Manual, Volume 1 & 2 (Professional Edition) HCPCS Level II Manual The following 10 sample pages are from HCpro’s 2011 ICD-9-CM Coding Manual, Volumes 1, 2 & 3 SaMple pageS ICD-9-CM Manual, Volumes 1, 2 & 3 (Hospital Edition) 2011 ICD-9-CM Conventions HCPro’s ICD-9-CM manuals include all the symbols and conventions Please note: Certain categories of codes only consider a particular set of found in the government’s official version (see Preface and ICD-9-CM fifth digits to be a CC condition. Official Guidelines for Coding and Reporting). In addition, HCPro’s ICD- • For example: 9-CM manuals include the following icons and color-coded conventions: Category 403.9x. CC 1 ✓4 TH Fourth digit required. In order to accurately assign a diagnosis This means that ICD-9 code 403.90 is not considered a CC condition, but from this category, it requires the assignment of a fourth digit. 403.91 is designated as a CC condition. • For example: Category 465.x requires a fourth digit of a 0, 8, or 9 to be assigned an accurate code. MCC Major Complication and Comorbidity. This diagnosis is considered a major complication and/comorbidity. Assignment of these ✓5 TH Fifth digit required. In order to accurately assign a diagnosis from diagnoses as an additional code may impact DRG assignment. this category, it requires the assignment of a fifth digit. • For example: 585.6 (End stage renal disease) is • For example: Category 642.0x requires a fifth digit of a 0, 1, 2, 3, or designated as an MCC.
    [Show full text]
  • Contemporary Outcomes After Pericardial Window Surgery: Impact of Operative Technique Sarah E
    Langdon et al. Journal of Cardiothoracic Surgery (2016) 11:73 DOI 10.1186/s13019-016-0466-3 RESEARCH ARTICLE Open Access Contemporary outcomes after pericardial window surgery: impact of operative technique Sarah E. Langdon, Kristen Seery and Alexander Kulik* Abstract Background: The optimal window procedure for drainage of a large pericardial effusion has yet to be established. The purpose of this study was to compare the outcomes associated with the subxiphoid and thoracotomy pericardial window techniques, with a focus on perioperative pain and effusion recurrence rates. Methods: A retrospective single-center observational study of all pericardial window operations was performed, with the incision based on surgeon preference. Perioperative data was recorded including time to extubation, narcotic requirements, and the development of a recurrent pericardial effusion. Results: From 2002 to 2015, 179 patients with a large pericardial effusion underwent either a subxiphoid (n =127)orleft anterior mini-thoracotomy (n = 52) pericardial window procedure. Patients (mean age 73.2 years, 56 % female) had a high incidence of previous malignancy (49 %), chronic anticoagulation (34 %), recent infection (26 %), or renal failure (18 %). Cardiac tamponade was present in 50 %, and 12 % had undergone previous pericardiocentesis. Comparing the two techniques, there was no difference in the amount of fluid drained or in the perioperative mortality rate. Postoperatively, patients who had the subxiphoid approach required less time before extubation (P = 0.002) and needed less narcotics within 48 h after surgery (P = 0.0001) compared to thoracotomy patients. However, patients treated with the subxiphoid technique more often developed recurrent moderate or large pericardial effusions (P = 0.02), and there was a trend towards more repeat operations needed (P =0.15).
    [Show full text]
  • Abouzeid M, Wyber R, La Vincente S, Sliwa K, Zuhlke L, Mayosi B, Et Al
    Professor Bongani Mayosi: Bibliography 2019 Abouzeid M, Wyber R, La Vincente S, Sliwa K, Zuhlke L, Mayosi B, et al. Time to tackle rheumatic heart disease: Data needed to drive global policy dialogues. Glob Public Health. 2019;14(3):456–468. doi: 10.1080/17441692.2018.1515970. Full text not freely available. Rheumatic heart disease (RHD) is an avoidable disease of poverty that persists predominantly in low resource settings and among Indigenous and other high-risk populations in some high-income nations. Following a period of relative global policy inertia on RHD, recent years have seen a resurgence of research, policy and civil society activity to tackle RHD; this has culminated in growing momentum at the highest levels of global health diplomacy to definitively address this disease of disadvantage. RHD is inextricably entangled with the global development agenda, and effective RHD action requires concerted efforts both within and beyond the health policy sphere. This report provides an update on the contemporary global and regional policy landscapes relevant to RHD, and highlights the fundamental importance of good data to inform these policy dialogues, monitor systems responses and ensure that no one is left behind. Chasseuil E, McGrath JA, Seo A, Balguerie X, Bodak N, Chasseuil H, et al. Dermatological manifestations of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis (POIKTMP): A case series of 28 patients. Br J of Dermatol. 2019. doi: 10.1111/bjd.17996. Full text not freely available. Hereditary Fibrosing Poikiloderma with Tendon Contractures, Myopathy and Pulmonary Fibrosis (POIKTMP [MIM 615704]) is a recently described autosomal dominant disorder due to missense mutations in the FAM111B gene.
    [Show full text]
  • Evaluation of Thoracoscopic Pericardial Window Size and Execution Time in Dogs: Comparison of Two Surgical Approaches
    animals Article Evaluation of Thoracoscopic Pericardial Window Size and Execution Time in Dogs: Comparison of Two Surgical Approaches Francesco Macrì 1, Vito Angileri 1, Claudia Giannetto 1 , Lorenzo Scaletta 2, Piero Miele 2, Loris Pazzaglia 3 and Simona Di Pietro 1,* 1 Department of Veterinary Sciences, University of Messina, Viale Palatucci, 98168 Messina, Italy; [email protected] (F.M.); [email protected] (V.A.); [email protected] (C.G.) 2 Veterinaria Enterprise Stp S.R.L., Via Galvani 33d, 00153 Rome, Italy; [email protected] (L.S.); [email protected] (P.M.) 3 Clinica Veterinaria Galilei, Via B. Franklin 22, 59100 Prato, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-090-6766758 Simple Summary: This canine prospective study was performed to statistically compare the surgery time and achieved windows size of two different thoracoscopic pericardiectomy techniques in dogs affected by pericardial effusion, using transdiaphragmatic paraxyphoid and monolateral intercostal approaches. The paraxifoid and the monolateral intercostal approaches showed a mean surgical time of 55 ± 20.08 (SD) minutes and 13.94 ± 4.61 (SD) minutes, and a mean pericardial window diameter of 4.23 ± 0.80 (SD) cm and 3.31 ± 0.43 (SD) cm, respectively. A significant correlation was observed between the dogs’ bodyweight and window size (r = 0.48; p = 0.04) for both surgical approaches, and between the dogs’ bodyweight and surgical time (r = 0.72; p = 0.0016) for monolateral intercostal Citation: Macrì, F.; Angileri, V.; approach. Our results provided useful information to help surgeons make the definitive choice of the Giannetto, C.; Scaletta, L.; Miele, P.; surgical technique to treat the pericardial effusion.
    [Show full text]
  • The Department of Anesthesiology & Perioperative Medicine Faculty of Medicine Queen’S University
    Department of Anesthesiology, Queen’s University Residency Program Goals, Objectives and Evaluation Page 1 of 187 THE DEPARTMENT OF ANESTHESIOLOGY & PERIOPERATIVE MEDICINE FACULTY OF MEDICINE QUEEN’S UNIVERSITY POSTGRADUATE EDUCATION PROGRAM IN ANESTHESIOLOGY GOALS AND OBJECTIVES MANUAL Revised October 15, 2014 Department of Anesthesiology, Queen’s University Residency Program Goals, Objectives and Evaluation Page 2 of 187 THE DEPARTMENT OF ANESTHESIOLOGY & PERIOPERATIVE MEDICINE FACULTY OF MEDICINE QUEEN’S UNIVERSITY POSTGRADUATE EDUCATION PROGRAM IN ANESTHESIOLOGY GOALS AND OBJECTIVES MANUAL Table of Contents: Section Goals …………………………………………………………………………………I Introduction Objectives for Training in Anesthesiology Terminal Goals of the Training Program in Anesthesiology at Queen’s RCPSC Objectives of Training in Anesthesia CanMEDS 2005 Framework for Physician Competencies Guidelines for Graded Responsibility Concurrent Coverage Objectives of the Postgraduate Program in Anesthesiology: PGY1 Objectives ……………….………………………………………… II Block Rotation Objectives………………………………………………… III Critical Care, NICU, and Medicine Objectives …………………………… IV Block Science Objectives Basic Science ……………………………………………………. V Clinical Science………………………………………………….. VI Ancillary Objectives ……………………………………………………………….. Appendix A Professional Skills Personal Attitudes and Ethics Basic Science Objectives Clinical Science Objectives Department of Anesthesiology, Queen’s University Residency Program Goals, Objectives and Evaluation Page 3 of 187 OVERVIEW OF THE ACADEMIC PROGRAM
    [Show full text]